New oral treatment could replace injections for kids with growth hormone deficiency
NCT ID NCT07264595
Summary
This study is testing a new oral medication called GS3-007a for children with growth hormone deficiency. The first part aims to find a safe dose, and the second part will compare the medication's effect on growth over one year against an existing treatment. Eligible children are at least 3 years old, prepubertal, and have a confirmed diagnosis of growth hormone deficiency.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC GROWTH HORMONE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.